Leadership » C-DOCTOR

C-DOCTOR Leadership Council

The Leadership Council consists of established leaders in their field who bring tremendous collective scientific, clinical, and biotech business development expertise to the team. With shared, vested interest in ITP success, the Leadership Council collaborate to utilize their extensive experience to guide new technologies to clinical trials and commercial partnerships. Click on their profiles to read more about their experience.

Jeffrey Lotz, PhD

University of California, San Francisco

Jeffrey Lotz, PhD

University of California, San Francisco

Dr. Lotz is co-PI of C-DOCTOR and the UCSF site PI. As founding director of the NIH Core Center for Musculoskeletal Biology in Medicine and the Orthopaedic Surgery Industry Research Center, he wields extensive experience in building consensus among diverse groups and delivering value to stakeholders. His network of professional colleagues and experience in presenting pre-clinical data to the FDA, forming companies that are now in clinical trials, developing diagnostic tools, and testing biologic therapies contribute to the success of C-DOCTOR.

Yang Chai, DDS, PhD

University of Southern California

Yang Chai, DDS, PhD

University of Southern California

Dr. Chai is co-PI of C-DOCTOR and the USC site PI. With over 140 peer-reviewed papers, he has extensive experience in investigating the molecular and cellular regulatory mechanisms of craniofacial development and stem cells and securing NIH funding. His commitment to improving patient care through regenerative medicine and tissue engineering drives the success of C-DOCTOR.

Michael Jamieson, DRsc

Core Resource Director

Michael Jamieson, DRsc

Core Resource Director

Dr. Jamieson is the Internal Resource Director of Regulatory/Reimbursement for C-DOCTOR and assists the ITP teams in identifying regulatory and reimbursement strategies. He has an in-depth understanding of what industries’ expectations are with respect to working with academic researchers and what steps are needed to improve the current model for the translation of academic-based research projects. Dr. Jamieson's experience guides C-DOCTOR’s development of best practices for calibration, validation, and qualification of equipment, as well as data reproducibility.

Scott Fraser, PhD

University of Southern California

Scott Fraser, PhD

University of Southern California

Dr. Fraser is a USC site PI. He has over 200 publications and dozens of patents and has founded extensive imaging, engineering, and research centers at USC, CHLA, and Caltech. These accomplishments, along with his experience in performing multidisciplinary studies of the cellular and molecular bases of complex biological phenomena, contribute to the C-DOCTOR’s ability to foster interaction between diverse groups of researchers and translate new results into clinical utility.

Kevin Healy, PhD

University of California, Berkeley

Kevin Healy, PhD

University of California, Berkeley

Dr. Healy is the site PI at UC Berkeley. He leads an interdisciplinary group that focuses on bioinspired stem cell microenvironments to control stem cell lineage specification and self-organization into microtissues, bioinspired systems for regenerative medicine, biological interfaces, and microphysiological systems for drug development, gene editing, and toxicity screening. His insight on the interface between biology and materials science to develop engineered systems for fundamental biological phenomena and translational medicine applications is vital to C-DOCTOR.

Nancy Lane, MD

University of California, Davis

Nancy Lane, MD

University of California, Davis

Dr. Lane is a key consultant on the C-DOCTOR leadership council. She has extensive experience in developing technologies to address salivary gland regeneration, craniofacial tissues, and rheumatic diseases, as well as expertise in performing IND-enabling studies. She is a vital member of the C-DOCTOR leadership council and offers her expertise, network with contract research organizations, and intimate knowledge of all projects in the portfolio to advise member projects and guide them to success.

Michael Longaker, MD, MBA

Stanford University

Michael Longaker, MD, MBA

Stanford University

Dr. Longaker is the Stanford University site PI. Dr. Longaker has considerable experience as a surgeon-scientist directing large research programs at Stanford University, evident through a record of successful and productive research projects in skeletal stem cells, adipose-derived stromal cells, craniofacial biology, bone tissue engineering, and wound repair. His experience and expertise in both clinical research and administration are vital to C-DOCTOR’s ability to develop effective research plans, timelines, and budgets to further the success of multiple projects.

Mark Urata, MD, DDS

University of Southern California

Mark Urata, MD, DDS

University of Southern California

Dr. Urata is a site PI at USC. Holding significant positions of leadership at CHLA, Keck School of Medicine, and USC Ostrow School of Dentistry, he has developed new techniques to improve current procedures and looked at the outcomes of these novel surgical procedures to treat rare conditions such as Pierre Robin Sequence in addition to cleft lip and palate. Dr. Urata is pivotal to C-DOCTOR through his recruitment of clinical advisors and his experience in shepherding a translational medicine project to bring a treatment from bench to bedside.  

Benjamin Wu, DDS, PhD

C-DOCTOR

Benjamin Wu, DDS, PhD

C-DOCTOR

Dr. Wu is a key consultant on the C-DOCTOR leadership council. His research has made significant contributions in tissue repair/regeneration and manufacturing of medical devices as evidenced by his 230+ peer-reviewed articles and 20 issued patents. Dr. Wu provides necessary guidance to C-DOCTOR through his work in the biofabrication of biomaterials systems to deliver cells, proteins, and genes to promote the repair of hard and soft tissues; manufacturing medical devices using bioengineering approaches; and pioneering contributions to 3D printing of biomedical devices.

Operations Committee

The Operations Committee (OC) Leadership serves as the primary liaisons between the Leadership Council and the administrative staff at partner sites and ITP home institutions. The OC is vital in supporting ITPs, enabling them to make maximal use of the C-DOCTOR resources available to them.

Bridget Samuels, PhD

University of Southern California

Bridget Samuels, PhD

University of Southern California

Email:[email protected]

VyVy Nguyen, MPH

University of Southern California

VyVy Nguyen, MPH

University of Southern California

Email:[email protected]

Pui Yee Law

University of California, San Francisco

Pui Yee Law

University of California, San Francisco

Email:[email protected]

Chase Linsley, PhD

University of California, Los Angeles

Chase Linsley, PhD

University of California, Los Angeles

Paulo Pereira

Stanford University

Paulo Pereira

Stanford University

C-DOCTOR

A national resource center for the clinical translation of innovative regenerative technologies to replace dental, oral, and craniofacial (DOC) tissues or organs lost to congenital disorders, traumatic injuries, diseases, and medical procedures.

Jeffrey Lotz, Co-PI
Yang Chai, Co-PI

Pui Yee Law, Operations
Bridget Samuels, Operations
VyVy Nguyen, Operations

[email protected]
[email protected]

[email protected]
[email protected]
[email protected]

Click here to join our newsletter!

C-DOCTOR is supported by U24 DE029463 from the National Institute of Dental & Craniofacial Research, National Institutes of Health.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.